Hanall Biopharma Co.,Ltd (009420.KS) KSC

51,800.00

-4200(-7.50%)

Updated at December 05 10:41AM

Currency In KRW

Valuation

Market Cap1.96T
Enterprise Value1.95T
P/E Ratio1,300.8
PEG Ratio5.6
Price/Sales Ratio18.94
Price/Book Ratio18.61
Enterprise/Revenue18.89
Enterprise/EBITDA104.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.03

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue138.94B
Revenue/Share2,893.11
Gross Profit73.31B
EBITDA3.35B
Net Income-1.8B
Diluted EPS-35.59

Balance Sheet

Total Cash8.54B
Total Cash/Share164.57
Total Debt1.37B
Total Debt/Equity0.01
Current Ratio2.5
Book Value Per Share3,009.11

Price History

52-Week Change56.86
52-Week High57,100
52-Week Low24,000
Moving Average 50 Days39,277
Moving Average 200 Days31,484.5

Statistics

Average Volume800,405
Shares Outstanding50.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor263:250
Last Split DateMay 24, 2006